Epstein-Barr virus and methotrexate-related CNS lymphoma in a patient with rheumatoid arthritis

被引:16
作者
Migita, Kiyoshi [1 ]
Miyashita, Taiichiro [1 ]
Mijin, Toma [1 ]
Sakito, Sohko [2 ]
Kurohama, Hirokazu [3 ]
Ito, Masahiro [3 ]
Toda, Keisuke [4 ]
Tsustumi, Keisuke [4 ]
Baba, Hiroshi [4 ]
Izumi, Yasumori [1 ]
Kawakami, Atsushi [5 ]
Niino, Daisuke [6 ]
Ohshima, Kouichi [6 ]
机构
[1] NHO Natl Nagasaki Med Ctr, Dept Gen Internal Med & Rheumatol, Clin Res Ctr, Omura 8568652, Japan
[2] Sadamatsu Hosp, Dept Rheumatol, Omura 8500034, Japan
[3] NHO Natl Nagasaki Med Ctr, Dept Pathol, Omura 8568652, Japan
[4] NHO Natl Nagasaki Med Ctr, Dept Neurosurg, Omura 8568652, Japan
[5] Nagasaki Univ Hosp, Dept Rheumatol, Nagasaki, Japan
[6] Kurume Univ, Dept Pathol, Sch Med, Kurume, Fukuoka 8300011, Japan
关键词
CNS lymphoma; Epstein-Barr virus; Methotrexate; Rheumatoid arthritis; LYMPHOPROLIFERATIVE DISORDERS; DISEASES;
D O I
10.1007/s10165-012-0717-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with rheumatoid arthritis (RA), especially those treated with methotrexate (MTX), might have an increased risk of lymphoproliferative disorders that are associated with Epstein-Barr virus (EBV). We describe a case of EBV-associated central nervous system (CNS) lymphoma (diffuse large B-cell lymphoma) in a patient with RA on a short course of MTX treatment. The neoplastic cells express the B-cell surface markers (CD20, Pax-5 and CD30), and EBV-encoded RNA was demonstrated by in situ hybridization. The patient's lymphoma did not recur for the 8-year follow-up period after the tumor resection and cessation of MTX. MTX may promote EBV-positive CNS lymphoma in RA patient due to its immunosuppressive properties as well as reactivating latent EBV infection.
引用
收藏
页码:832 / 836
页数:5
相关论文
共 13 条
[1]   Primary central nervous system lymphomas [J].
Batara, JF ;
Grossman, SA .
CURRENT OPINION IN NEUROLOGY, 2003, 16 (06) :671-675
[2]  
Dawson TM, 2001, J RHEUMATOL, V28, P47
[3]   PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMA [J].
FINE, HA ;
MAYER, RJ .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (11) :1093-1104
[4]  
Hoshida Y, 2007, J RHEUMATOL, V34, P322
[5]   Epstein-Barr virus-associated malignancies: epidemiologic patterns and etiologic implications [J].
Hsu, JL ;
Glaser, SL .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2000, 34 (01) :27-53
[6]   Epstein Barr Virus-Associated Primary CNS Lymphomas in Elderly Patients on Immunosuppressive Medications [J].
Kleinschmidt-DeMasters, B. K. ;
Damek, Denise M. ;
Lillehei, Kevin O. ;
Dogan, Ahmed ;
Giannini, Caterina .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2008, 67 (11) :1103-1111
[7]   Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France [J].
Mariette, X ;
Cazals-Hatem, D ;
Warszawki, J ;
Liote, F ;
Balandraud, N ;
Sibilia, J .
BLOOD, 2002, 99 (11) :3909-3915
[8]   EBV-associated lymphoproliferative disorder of CNS associated with the use of mycophenolate mofetil [J].
O'Neill, Brian Patrick ;
Vernino, Steven ;
Dogan, Ahmet ;
Giannini, Caterina .
NEURO-ONCOLOGY, 2007, 9 (03) :364-369
[9]   Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases [J].
Salloum, E ;
Cooper, DL ;
Howe, G ;
Lacy, J ;
Tallini, G ;
Crouch, J ;
Schultz, M ;
Murren, J .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (06) :1943-1949
[10]   Rheumatoid arthritis [J].
Scott, David L. ;
Wolfe, Frederick ;
Huizinga, Torn W. J. .
LANCET, 2010, 376 (9746) :1094-1108